Benzinga's Top Pre-Market Gainers
OraSure Technologies (NASDAQ: OSUR) surged 10.91% to $13.42 in the pre-market session. The US Food and Drug Administration approved OraSure's OraQuick(R) In-Home HIV Test.
MannKind (NASDAQ: MNKD) added 7% to $2.75 in the pre-market session. MannKind's PEG ratio is 0.02.
PhotoMedex (NASDAQ: PHMD) soared 4.16% to $13.03 in the pre-market trading. PhotoMedex announced settlement of all litigation with TRIA Beauty.
© 2016 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.